Embla Medical hf. (OSSFF)
OTCMKTS · Delayed Price · Currency is USD
4.850
0.00 (0.00%)
At close: Feb 9, 2026

Embla Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2,0452,1832,1101,7112,0252,732
Market Cap Growth
-0.03%3.48%23.32%-15.52%-25.86%-18.70%
Enterprise Value
2,4942,6462,5392,1162,4493,115
Last Close Price
4.855.334.774.214.636.05
PE Ratio
24.5326.2030.9029.3047.6442.69
PS Ratio
2.202.352.472.182.823.80
PB Ratio
2.282.442.702.433.194.36
P/FCF Ratio
18.5019.7523.7026.2945.8032.69
P/OCF Ratio
15.4216.4618.1818.1433.3327.17
EV/Sales Ratio
2.662.852.972.693.414.34
EV/EBITDA Ratio
13.2617.6318.5519.5427.3725.99
EV/EBIT Ratio
18.7821.2222.5224.2036.4732.58
EV/FCF Ratio
22.5623.9428.5232.5155.3737.28
Debt / Equity Ratio
0.610.610.640.660.760.72
Debt / EBITDA Ratio
3.023.023.083.584.353.17
Debt / FCF Ratio
4.904.905.617.1910.885.36
Asset Turnover
0.570.570.590.580.560.58
Inventory Turnover
2.272.272.292.242.362.67
Quick Ratio
0.830.831.031.050.821.02
Current Ratio
1.481.481.901.921.471.71
Return on Equity (ROE)
9.98%9.98%9.28%8.77%6.85%10.91%
Return on Assets (ROA)
4.77%4.77%4.82%4.03%3.26%4.86%
Return on Invested Capital (ROIC)
7.25%7.64%7.48%6.32%5.09%7.44%
Return on Capital Employed (ROCE)
8.80%8.80%8.50%7.40%6.20%9.00%
Earnings Yield
4.08%3.82%3.24%3.41%2.10%2.34%
FCF Yield
5.41%5.06%4.22%3.80%2.18%3.06%
Buyback Yield / Dilution
-0.08%-0.08%-1.51%-0.60%1.17%-0.02%
Total Shareholder Return
-0.08%-0.08%-1.51%-0.60%1.17%-0.02%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.